SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-09-040401
Filing Date
2009-08-12
Accepted
2009-08-12 21:56:35
Documents
2
Period of Report
2009-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4117
2 POA DOCUMENT poa.txt EX-24.4_297021 4539
  Complete submission text file 0001209191-09-040401.txt   10451
Mailing Address C/O COLEY PHARMACEUTICAL GROUP, INC. 93 WORCESTER STREET, SUITE 101 WELLESLEY MA 02481
Business Address
Abdalian Charles H Jr (Reporting) CIK: 0001335290 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33284 | Film No.: 091008313

Mailing Address 160 SECOND STREET CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE MA 02142 617-492-5554
Molecular Insight Pharmaceuticals, Inc. (Issuer) CIK: 0001340752 (see all company filings)

IRS No.: 043412465 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations